BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 115635
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.115635
Deep learning radiomics nomogram based on multi-regional features for predicting lymph node metastasis and prognosis in colorectal cancer
Yong-Hai Li, Rui Du, Yuan-Cheng Liu, Zi-Qi Tang, Zhi-Gang Sun, Gui-Xiang Qian, Xue-Di Lei
Xue-Di Lei, Zi-Qi Tang, Yong-Hai Li, Graduate School, Bengbu Medical University, Bengbu 233000, Anhui Province, China
Xue-Di Lei, Gui-Xiang Qian, Zi-Qi Tang, Department of General Surgery, The First People’s Hospital of Hefei, Hefei 230001, Anhui Province, China
Zhi-Gang Sun, Department of General Surgery, The Chinese People’s Armed Police Forces Anhui Provincial Corps Hospital, Hefei 230041, Anhui Province, China
Yuan-Cheng Liu, Rui Du, Yong-Hai Li, Department of Anorectal Surgery, The First People’s Hospital of Hefei, Hefei 230001, Anhui Province, China
Co-first authors: Xue-Di Lei and Gui-Xiang Qian.
Author contributions: Lei XD and Qian GX made indispensable contributions to the conception, design, data acquisition, analysis, interpretation of the clinical and imaging data, and the writing of the manuscript, they contributed equally to this article, they are the co-first authors of this manuscript; Lei XD, Sun ZG, and Tang ZQ were involved in the acquisition, analysis, and interpretation of clinical and imaging data; Lei XD, Liu YC, and Li YH participated in the conception and design of the study; Qian GX and Du R performed the radiomics feature extraction and statistical analysis; and all authors thoroughly reviewed and endorsed the final manuscript.
Supported by the Anhui Provincial Research Project on the Inheritance and Innovation of Traditional Chinese Medicine, No. 2024CCCX007; and the Graduate Research and Innovation Program of Bengbu Medical University, No. Byycxz24046.
Institutional review board statement: This study was approved by the Medical Ethics Committee of the First People’s Hospital of Hefei, approval No. 22025-158-01.
Informed consent statement: Due to the retrospective nature of the study, the requirement for informed consent was waived.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: Due to patient privacy concerns, the datasets used and/or analyzed during the study are not publicly available but can be obtained from the corresponding author upon reasonable request.
Corresponding author: Yong-Hai Li, MD, Department of Anorectal Surgery, The First People’s Hospital of Hefei, No. 390 Huaihe Road, Hefei 230001, Anhui Province, China. liyonghai@ahmu.edu.cn
Received: October 22, 2025
Revised: December 4, 2025
Accepted: February 4, 2026
Published online: April 15, 2026
Processing time: 169 Days and 4.1 Hours
Abstract
BACKGROUND

Lymph node metastasis (LNM) is closely linked to poor prognosis in patients with colorectal cancer (CRC). An accurate preoperative evaluation of lymph node status is crucial for tailoring individualized treatment plans. However, dependable methods for predicting lymph node involvement and assessing prognosis prior to surgery are still inadequate.

AIM

To develop a nomogram combining clinical features, radiomics and deep learning (DL) features for predicting LNM and prognosis in patients with resectable CRC.

METHODS

Two hundred and seventy-eight patients with pathologically confirmed CRC from two hospitals were retrospectively enrolled. Radiomics and DL features were extracted from preoperative three-phase contrast-enhanced computed tomography images within the intratumoral and peritumoral-3 mm regions. Using logistic regression combined with three feature selection methods, a clinical-DL-radiomics nomogram (DLRN) was developed. SHapley Additive exPlanations were employed to interpret the model. Additionally, Cox regression analysis was performed to identify risk factors for 3-year recurrence-free survival and to construct a prognostic model.

RESULTS

The DLRN demonstrated significantly superior performance in differentiating LNM compared to both the clinical model and the radiomics model. The area under the receiver operating characteristic curve for the DLRN was 0.944, 0.878, and 0.855 in the training, internal validation, and external validation cohorts, respectively. Calibration curves and decision curve analysis confirmed that the DLRN exhibited excellent calibration and strong clinical utility. Furthermore, the prognostic model based on the DLRN score showed robust performance in predicting 3-year recurrence-free survival, achieving an area under the receiver operating characteristic curves of 0.826, 0.788, and 0.755 across the three cohorts, respectively.

CONCLUSION

The DLRN demonstrated excellent performance in predicting LNM in CRC. Additionally, the prognostic model derived from the DLRN score effectively stratified patients according to their risk of recurrence.

Keywords: Colorectal cancer; Radiomics; Deep learning; Lymph node metastasis; Prognosis; Contrast-enhanced computed tomography; Nomogram; SHapley Additive exPlanation

Core Tip: Accurate preoperative prediction of lymph node metastasis is crucial for optimizing treatment strategies in colorectal cancer. In this study, we developed an interpretable clinical-deep learning-radiomics nomogram (DLRN) by integrating clinical features with multi-regional radiomics and deep learning features. Moreover, the DLRN-based prognostic model effectively predicted 3-year recurrence-free survival. As a noninvasive preoperative tool, the DLRN demonstrated strong predictive accuracy for lymph node metastasis in colorectal cancer and offers a practical means for individualized risk stratification and informed treatment decision-making.